Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.
Alchemab takes an unbiased and function-first approach using three complementary processes and cutting-edge technologies to identify naturally protective antibodies.
Alchemab’s engine is enabled through collaborations with patient representative groups and biobanks around the world with whom we partner to further our understanding of disease.
Location: United Kingdom, England, London
Employees: 11-50
Total raised: $82.59M
Founded date: 2019
Founders name: Uri Laserson
Founders Related Locations: United States, New York, New York
Investors 5
| Date | Name | Website |
| - | DCVC | dcvc.com/ |
| - | RA Capital... | racap.com |
| 22.04.2021 | Lightstone... | lightstone... |
| - | DHVC | dh.vc |
| - | SV Health ... | svhealthin... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.04.2021 | Series A | $82.59M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Uri | Laserson | Scientific... | linkedin.c... | - | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 08.03.2024 | On International Women's Day SV Venture Partner Ruth McKerna... | On International Women’s Day it is extremely pleasing to note the vast majority of SV Health Investo... | svhealthin... |
| 26.05.2022 | Alchemab appoints Young T. Kwon as Chief Executive Officer | Waltham, Massachusetts and Cambridge, UK May 26, 2022 – Alchemab Therapeutics, a biotechnology compa... | svhealthin... |
| 22.06.2021 | Alchemab Therapeutics Appoints Douglas A. Treco, PhD as Chie... | Industry Veteran Brings Experience and Proven Track Record of Success | svhealthin... |
| 05.05.2021 | Alchemab to collaborate with AstraZeneca to use Alchemab’s d... | Alchemab to collaborate with AstraZeneca to use Alchemab’s drug discovery platform for prostate canc... | cambridgen... |
| 15.04.2021 | Alchemab raises £60M ($82M) in Series A financing to advance... | April 15, 2021 04:00 AM Eastern Daylight Time | svhealthin... |
| 15.04.2021 | Alchemab raises £60M ($82M) in Series A financing to advance... | Alchemab Therapeutics, a biotech company developing novel products for patients with hard-to-treat d... | marketscre... |
| 15.04.2021 | Alchemab raises £60 million in Series A financing to advance... | Alchemab raises £60 million in Series A financing to advance novel platform for identifying disease-... | cambridgen... |
| 16.03.2021 | Alchemab and Medicines Discovery Catapult to develop landmar... | March 16, 2021 05:00 AM Eastern Daylight Time | svhealthin... |
| 29.09.2020 | Alchemab partners with Amii to accelerate the development of... | EDMONTON, AB (September 29, 2020) – Alchemab, a UK biotech company focused on harnessing the power o... | svhealthin... |
| 18.09.2020 | SV Health Investors welcomes six new Venture Partners to the... | Boston, MA & London, UK (September 18, 2020) – SV, a leading transatlantic healthcare venture ca... | svhealthin... |
Show more